Literature DB >> 27195607

Human coronavirus and severe acute respiratory infection in Southern Brazil.

Hygor Trombetta1, Heloisa Z Faggion1, Jaqueline Leotte1, Meri B Nogueira2,3, Luine R R Vidal2, Sonia M Raboni1,2.   

Abstract

Human coronaviruses (HCoVs) are an important cause of respiratory tract infection and are responsible for causing the common cold in the general population. Thus, adequate surveillance of HCoV is essential. This study aimed to analyze the impact of HCoV infections and their relation to severe acute respiratory infection (SARI) in a hospitalized population in Southern Brazil. A cross-sectional study was conducted at a tertiary care hospital, and assessed inpatients under investigation for SARI by the hospital epidemiology department, and all patients who had nasopharyngeal aspirates collected from January 2012 to December 2013 to detect respiratory viruses (RVs). Viral infection was detected by multiplex reverse transcriptase polymerase chain reaction (RT-PCR), with primers specific to the subtypes HCoV-229E/NL63 and OC43/HKU1. The overall positivity rate was 58.8% (444/755), and HCoVs were detected in 7.6% (n = 34) of positive samples. Children below two years of age were most frequently affected (62%). Comorbidities were more likely to be associated with HCoVs than with other RVs. Immunosuppression was an independent risk factor for HCoV infection (OR = 3.5, 95% CI 1.6-7.6). Dyspnea was less frequently associated with HCoV infection (p < 0.001), and HCoV accounted for 6% of the SARI cases. Three patients infected with HCoV (9%) died from respiratory infection. HCoVs are important respiratory pathogens, especially in hospitalized children under 2 years of age and in immunosuppressed patients. They may account for a small proportion of SARI diagnoses, increased need for mechanical ventilation, intensive care unit admission, and death.

Entities:  

Keywords:  Epidemiology; Human Coronavirus; RT-PCR multiplex; Respiratory infections; Severe acute respiratory infection

Mesh:

Year:  2016        PMID: 27195607      PMCID: PMC4984956          DOI: 10.1080/20477724.2016.1181294

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  20 in total

1.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

Review 2.  The novel human coronaviruses NL63 and HKU1.

Authors:  Krzysztof Pyrc; Ben Berkhout; Lia van der Hoek
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

3.  Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia.

Authors:  Patrick C Y Woo; Susanna K P Lau; Chung-ming Chu; Kwok-hung Chan; Hoi-wah Tsoi; Yi Huang; Beatrice H L Wong; Rosana W S Poon; James J Cai; Wei-kwang Luk; Leo L M Poon; Samson S Y Wong; Yi Guan; J S Malik Peiris; Kwok-yung Yuen
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Characterization of human coronavirus OC43 and human coronavirus NL63 infections among hospitalized children <5 years of age.

Authors:  Jina Lee; Gregory A Storch
Journal:  Pediatr Infect Dis J       Date:  2014-08       Impact factor: 2.129

5.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

Authors:  Ali M Zaki; Sander van Boheemen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  N Engl J Med       Date:  2012-10-17       Impact factor: 91.245

Review 6.  Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.

Authors:  David S Hui; Ziad A Memish; Alimuddin Zumla
Journal:  Curr Opin Pulm Med       Date:  2014-05       Impact factor: 3.155

7.  Viral aetiology of acute respiratory infections among children and associated meteorological factors in southern China.

Authors:  Binglin Cui; Dangui Zhang; Hui Pan; Fan Zhang; Jeremy Farrar; Frieda Law; H Rogier van Doorn; Beiyan Wu; William Ba-Thein
Journal:  BMC Infect Dis       Date:  2015-03-13       Impact factor: 3.090

8.  Clinico-epidemiological characteristics of acute respiratory infections caused by coronavirus OC43, NL63 and 229E.

Authors:  J Reina; C López-Causapé; E Rojo-Molinero; R Rubio
Journal:  Rev Clin Esp (Barc)       Date:  2014-06-21

9.  Seasonality and prevalence of respiratory pathogens detected by multiplex PCR at a tertiary care medical center.

Authors:  Christine M Litwin; James G Bosley
Journal:  Arch Virol       Date:  2013-07-24       Impact factor: 2.574

10.  Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populations.

Authors:  Edward E Walsh; Jae Hyun Shin; Ann R Falsey
Journal:  J Infect Dis       Date:  2013-08-06       Impact factor: 5.226

View more
  19 in total

1.  Isolation of Coronavirus NL63 from Blood from Children in Rural Haiti: Phylogenetic Similarities with Recent Isolates from Malaysia.

Authors:  Valery Madsen Beau De Rochars; John Lednicky; Sarah White; Julia Loeb; Maha A Elbadry; Taina Telisma; Sonese Chavannes; Marie Gina Anilis; Eleonora Cella; Massimo Ciccozzi; Bernard A Okech; Marco Salemi; J Glenn Morris
Journal:  Am J Trop Med Hyg       Date:  2016-10-31       Impact factor: 2.345

2.  Establishment and Application of a Universal Coronavirus Screening Method Using MALDI-TOF Mass Spectrometry.

Authors:  Leshan Xiu; Chi Zhang; Zhiqiang Wu; Junping Peng
Journal:  Front Microbiol       Date:  2017-08-09       Impact factor: 5.640

3.  Global Influenza Hospital-based Surveillance Network (GIHSN): results of surveillance of influenza and other respiratory viruses in hospitalised patients in Brazil, 2015.

Authors:  Sonia M Raboni; Fernanda E A Moura; Braulia C Caetano; Valéria M Avanzi; Luciane A Pereira; Meri B Nogueira; Luine R Vidal; Isabel C F Tavares; Florence K Pradel; Valentina S Picot; Joan Puig-Barbera; Marilda M Siqueira
Journal:  BMJ Open       Date:  2018-02-15       Impact factor: 2.692

4.  Rapid detection and monitoring of human coronavirus infections.

Authors:  A H L Bruning; H Aatola; H Toivola; N Ikonen; C Savolainen-Kopra; S Blomqvist; D Pajkrt; K C Wolthers; J O Koskinen
Journal:  New Microbes New Infect       Date:  2018-05-09

5.  Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019-a multi-centre observational study.

Authors:  Y Cen; X Chen; Y Shen; X-H Zhang; Y Lei; C Xu; W-R Jiang; H-T Xu; Y Chen; J Zhu; L-L Zhang; Y-H Liu
Journal:  Clin Microbiol Infect       Date:  2020-06-09       Impact factor: 8.067

6.  Intensive care admission for Coronavirus OC43 respiratory tract infections.

Authors:  D Vandroux; N Allou; J Jabot; G Li Pat Yuen; E Brottet; B Roquebert; O Martinet
Journal:  Med Mal Infect       Date:  2018-03       Impact factor: 2.152

7.  The 2019 coronavirus: Learning curves, lessons, and the weakest link.

Authors:  Richard Albert Stein
Journal:  Int J Clin Pract       Date:  2020-04       Impact factor: 2.503

Review 8.  COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement.

Authors:  Charlie Wang; Marius Rademaker; Christopher Baker; Peter Foley
Journal:  Australas J Dermatol       Date:  2020-05-03       Impact factor: 2.481

9.  Estimation of time-varying reproduction numbers underlying epidemiological processes: A new statistical tool for the COVID-19 pandemic.

Authors:  Hyokyoung G Hong; Yi Li
Journal:  PLoS One       Date:  2020-07-21       Impact factor: 3.240

10.  SARS-CoV-2: fear versus data.

Authors:  Yanis Roussel; Audrey Giraud-Gatineau; Marie-Thérèse Jimeno; Jean-Marc Rolain; Christine Zandotti; Philippe Colson; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2020-03-19       Impact factor: 5.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.